Elizabeth O Ofili

Elizabeth O Ofili

UNVERIFIED PROFILE

Are you Elizabeth O Ofili?   Register this Author

Register author
Elizabeth O Ofili

Elizabeth O Ofili

Publications by authors named "Elizabeth O Ofili"

Are you Elizabeth O Ofili?   Register this Author

40Publications

702Reads

33Profile Views

Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation.

Int J Environ Res Public Health 2018 12 4;15(12). Epub 2018 Dec 4.

Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijerph15122733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313800PMC
December 2018

Reducing Cardiovascular Disparities Through Community-Engaged Implementation Research: A National Heart, Lung, and Blood Institute Workshop Report.

Circ Res 2018 01;122(2):213-230

From the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (G.A.M., L.N.P., M.C.G.P., B.J.N., R.A.R., M.M.E.); Loyola University Medical School, Department of Public Health Sciences, Chicago, IL (R.S.C.); University of Virginia School of Nursing, Charlottesville (A.M.S.-R.); Johns Hopkins School of Medicine, Department of Medicine, Baltimore, MD (L.A.C.); Johns Hopkins Bloomberg School of Public Health, Department of Health, Behavior, and Society, Baltimore, MD (L.A.C.); Center for Prevention Implementation Methodology (Ce-PIM), Northwestern University Feinberg School of Medicine, Chicago, IL (J.D.S., C.H.B.); Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora (J.M.W.); Morehouse School of Medicine, Department of Medicine, Atlanta, GA (E.O.O.); Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (S.A., C.R.N., N.R., M.L.A.-S., J.P.R., C.A.P., D.C.G.); University of Mississippi Medical Center, John D. Bower School of Population Health, Jackson (B.M.B.); University of North Carolina at Chapel Hill School of Nursing (J.L.B.); Michigan State University College of Human Medicine, Department of Epidemiology and Biostatistics, East Lansing (D.F.-H.); National Human Genome Research Institute, Bethesda, MD (S.Y.G.); School of Public Health, University of Illinois at Chicago (W.H.G., K.S.W.); Office of the Director, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD (R.S.J., E.J.P.-S.); Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA (T.T.L.); Institute for Health Metrics and Evaluation, University of Washington, Seattle (A.H.M.); Department of Neurology, University of Louisville, KY (K.D.M.); Department of Population Health, Center for Healthful Behavior Change, New York University School of Medicine, New York (J.E.R.); Community-Campus Partnerships for Health, Raleigh, NC (A.R.); UK Medical Center, University of Kentucky, Department of Medical Behavioral Science, Lexington (N.E.S.); Department of Medicine, Jackson Heart Study, University of Mississippi Medical Center (M.S.); Office of Health Equity, Health Resources and Services Administration, Rockville, MD (G.K.S.); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (A.E.S.); and Social and Health Research Center, San Antonio, TX (R.P.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.117.312243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777283PMC
January 2018

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.

Circulation 2015 May 14;131(20):1763-71. Epub 2015 Apr 14.

From Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.M.G.); Duke University Medical Center, Durham, NC (K.J.A., G.M.F., C.M.O., S.E.M., K.L.L., A.F.H.); Mayo Clinic, Rochester, MN (M.M.R.); Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX (A.D.); Ottawa Heart Institute, Ontario, Canada (H.H.); Emory University, Atlanta, GA (J.B.); Cleveland Clinic, OH (W.H.W.T.); MetroHealth Campus of Case Western Reserve University, Cleveland, OH (M.E.D.); University of Vermont, Burlington (M.M.L.); Washington University, St. Louis, MO (D.L.M.); Hennepin County Medical Center, Minneapolis, MN (S.R.G.); Morehouse School of Medicine, Atlanta, GA (E.O.O.); Christiana Care Health System, Newark, DE (M.T.S.); University of Pennsylvania, Philadelphia (K.B.M., T.P.C.); Tufts Medical Center, Boston, MA (M.A.K.); Massachusetts General Hospital, Boston (M.J.S.); and National Heart, Lung, and Blood Institute, Bethesda, MD (M.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014536DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438785PMC
May 2015

Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium.

Clin Transl Sci 2013 Dec 3;6(6):435-43. Epub 2013 Oct 3.

Atlanta Clinical Translational Science Institute (ACTSI), RCMI Center of Excellence for Clinical and Translational Research, and Department of Medicine, Morehouse School of Medicine, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cts.12118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038384PMC
December 2013

Early alterations of the immune transcriptome in cultured progenitor cells from obese African-American women.

Obesity (Silver Spring) 2012 Jul 19;20(7):1481-90. Epub 2012 Jan 19.

Clinical Research Center, Morehouse School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/oby.2011.370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611330PMC
July 2012

Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.

J Hypertens 2010 Aug;28(8):1761-9

Diabetes and Cardiovascular Center, University of Missouri School of Medicine, and VA Medical Center, Columbia, Missouri 65212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0b013e32833af380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908201PMC
August 2010

The role of translational research in addressing health disparities: a conceptual framework.

Ethn Dis 2008 ;18(2 Suppl 2):S2-155-60

Research Centers in Minority Institutions Translational Research Network, Charles R. Drew University of Medicine and Science, Los Angeles, California 90062, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705204PMC
September 2008

Addressing health disparities through multi-institutional, multidisciplinary collaboratories.

Ethn Dis 2008 ;18(2 Suppl 2):S2-161-7

Research Centers in Minority Institutions Translational Research Network, Charles R. Drew University of Medicine and Science, Los Angeles, California 90062, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705198PMC
September 2008

Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.

J Womens Health (Larchmt) 2008 Jul-Aug;17(6):931-8

Morehouse School of Medicine, Atlanta, Georgia 30310, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jwh.2008.0499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942752PMC
September 2008

Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia.

J Natl Med Assoc 2008 Apr;100(4):360-8

Drexe University College of Medicine, Philadelphia, PA 19102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0027-9684(15)31268-2DOI Listing
April 2008

Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.

Am J Geriatr Cardiol 2008 Jan-Feb;17(1):27-36

University of Tennessee College of Medicine and Veterans Affairs Medical Center, Memphis, TN, USA.

View Article

Download full-text PDF

Source
March 2008

Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.

J Clin Hypertens (Greenwich) 2006 Jul;8(7):470-80

University of Missouri-Columbia and Harry S. Truman VA Medical Center, 65212, USA.

View Article

Download full-text PDF

Source
July 2006

Dispelling the myth of "aggressive" antihypertensive therapy.

J Clin Hypertens (Greenwich) 2006 Jan;8(1 Suppl 1):4-11

Morehouse School of Medicine, Atlanta, GA 30310, USA.

View Article

Download full-text PDF

Source
January 2006

Ultralate referral and presentation for renal replacement therapy: socioeconomic implications.

Am J Kidney Dis 2005 Nov;46(5):881-6

Renal Section, Clinical Research Center, Morehouse School of Medicine, Atlanta, GA 30310, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2005.08.003DOI Listing
November 2005

Ability of troponin T to predict angiographic coronary artery disease in patients with chronic kidney disease.

Am J Cardiol 2004 Sep;94(6):834-6

Department of Medicine, Morehouse School of Medicine, Grady Memorial Hospital, 720 West View Drive SW, Atlanta, GA 30310, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000291490400895
Publisher Site
http://dx.doi.org/10.1016/j.amjcard.2004.05.075DOI Listing
September 2004

Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease.

Am J Cardiol 2002 Sep;90(6):663-5

Renal Section, Department of Medicine, Morehouse School of Medicine, Atlanta, Georgia 30310, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0002-9149(02)02581-xDOI Listing
September 2002